197 related articles for article (PubMed ID: 28887275)
1. FFA4 (GPR120) as a fatty acid sensor involved in appetite control, insulin sensitivity and inflammation regulation.
Im DS
Mol Aspects Med; 2018 Dec; 64():92-108. PubMed ID: 28887275
[TBL] [Abstract][Full Text] [Related]
2. Functions of omega-3 fatty acids and FFA4 (GPR120) in macrophages.
Im DS
Eur J Pharmacol; 2016 Aug; 785():36-43. PubMed ID: 25987421
[TBL] [Abstract][Full Text] [Related]
3. Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases.
Christiansen E; Watterson KR; Stocker CJ; Sokol E; Jenkins L; Simon K; Grundmann M; Petersen RK; Wargent ET; Hudson BD; Kostenis E; Ejsing CS; Cawthorne MA; Milligan G; Ulven T
Br J Nutr; 2015 Jun; 113(11):1677-88. PubMed ID: 25916176
[TBL] [Abstract][Full Text] [Related]
4. Free-fatty acid receptor-4 (GPR120): Cellular and molecular function and its role in metabolic disorders.
Moniri NH
Biochem Pharmacol; 2016 Jun; 110-111():1-15. PubMed ID: 26827942
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Tool Compounds for the Free Fatty Acid Receptor 4 (FFA4/GPR120).
Hansen SV; Ulven T
Handb Exp Pharmacol; 2017; 236():33-56. PubMed ID: 27807695
[TBL] [Abstract][Full Text] [Related]
6. FFA4 receptor (GPR120): A hot target for the development of anti-diabetic therapies.
Liu HD; Wang WB; Xu ZG; Liu CH; He DF; Du LP; Li MY; Yu X; Sun JP
Eur J Pharmacol; 2015 Sep; 763(Pt B):160-8. PubMed ID: 26123847
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acids induce Ca(2+) mobilization responses in human colon epithelial cell lines endogenously expressing FFA4.
Kim JM; Lee KP; Park SJ; Kang S; Huang J; Lee JM; Sato K; Chung HY; Okajima F; Im DS
Acta Pharmacol Sin; 2015 Jul; 36(7):813-20. PubMed ID: 26005911
[TBL] [Abstract][Full Text] [Related]
8. Free fatty acid receptor GPR120 and pathogenesis of obesity and type 2 diabetes mellitus.
Mo XL; Wei HK; Peng J; Tao YX
Prog Mol Biol Transl Sci; 2013; 114():251-76. PubMed ID: 23317787
[TBL] [Abstract][Full Text] [Related]
9. Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.
Milligan G; Alvarez-Curto E; Watterson KR; Ulven T; Hudson BD
Br J Pharmacol; 2015 Jul; 172(13):3254-65. PubMed ID: 25131623
[TBL] [Abstract][Full Text] [Related]
10. Dietary Fatty Acids and Their Potential for Controlling Metabolic Diseases Through Activation of FFA4/GPR120.
Ulven T; Christiansen E
Annu Rev Nutr; 2015; 35():239-63. PubMed ID: 26185978
[TBL] [Abstract][Full Text] [Related]
11. The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivity.
Oh DY; Lagakos WS
Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):322-7. PubMed ID: 21587066
[TBL] [Abstract][Full Text] [Related]
12. GPR120: Mechanism of action, role and potential for medical applications.
Karakuła-Juchnowicz H; Róg J; Juchnowicz D; Morylowska-Topolska J
Postepy Hig Med Dosw (Online); 2017 Nov; 71(0):942-953. PubMed ID: 29176006
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases.
Wannick M; Bezdek S; Guillen N; Thieme M; Meshrkey F; Mousavi S; Seeling M; Nimmerjahn F; Mócsai A; Zillikens D; Sezin T; Sadik CD
Pharmacol Res Perspect; 2018 Dec; 6(6):e00438. PubMed ID: 30455959
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic signaling of the free-fatty acid receptors FFA1 and FFA4 in human breast carcinoma cells.
Karmokar PF; Moniri NH
Biochem Pharmacol; 2022 Dec; 206():115328. PubMed ID: 36309079
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of the free fatty acids receptor-1 and -4 (FFA1/GPR40 and FFA4/GPR120) in bovine endometrial cells.
Valenzuela P; Teuber S; Manosalva C; Alarcón P; Figueroa CD; Ratto M; Burgos RA; Hidalgo MA
Vet Res Commun; 2019 Aug; 43(3):179-186. PubMed ID: 31187404
[TBL] [Abstract][Full Text] [Related]
16. Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity.
Cintra DE; Ropelle ER; Moraes JC; Pauli JR; Morari J; Souza CT; Grimaldi R; Stahl M; Carvalheira JB; Saad MJ; Velloso LA
PLoS One; 2012; 7(1):e30571. PubMed ID: 22279596
[TBL] [Abstract][Full Text] [Related]
17. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice.
Oh DY; Walenta E; Akiyama TE; Lagakos WS; Lackey D; Pessentheiner AR; Sasik R; Hah N; Chi TJ; Cox JM; Powels MA; Di Salvo J; Sinz C; Watkins SM; Armando AM; Chung H; Evans RM; Quehenberger O; McNelis J; Bogner-Strauss JG; Olefsky JM
Nat Med; 2014 Aug; 20(8):942-7. PubMed ID: 24997608
[TBL] [Abstract][Full Text] [Related]
18. ω-3 Polyunsaturated fatty acids accelerate airway repair by activating FFA4 in club cells.
Lee KP; Park SJ; Kang S; Koh JM; Sato K; Chung HY; Okajima F; Im DS
Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L835-L844. PubMed ID: 28314803
[TBL] [Abstract][Full Text] [Related]
19. The beneficial effects of n-3 polyunsaturated fatty acids on diet induced obesity and impaired glucose control do not require Gpr120.
Bjursell M; Xu X; Admyre T; Böttcher G; Lundin S; Nilsson R; Stone VM; Morgan NG; Lam YY; Storlien LH; Lindén D; Smith DM; Bohlooly-Y M; Oscarsson J
PLoS One; 2014; 9(12):e114942. PubMed ID: 25541716
[TBL] [Abstract][Full Text] [Related]
20. Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist.
Sparks SM; Aquino C; Banker P; Collins JL; Cowan D; Diaz C; Dock ST; Hertzog DL; Liang X; Swiger ED; Yuen J; Chen G; Jayawickreme C; Moncol D; Nystrom C; Rash V; Rimele T; Roller S; Ross S
Bioorg Med Chem Lett; 2017 Mar; 27(5):1278-1283. PubMed ID: 28148462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
